Translation plagiarism is a type of disguised plagiarism which occurs when authorship credit is taken by someone who republishes the work of someone else, but in a different language. The difficulty of identifying this type of plagiarism is explored and the potential damage done by it, in the field of philosophy, examined.
A recent survey published in PLOS One of 6000 of the top cited authors examined how authorship is assigned, and what input was valued by the authors. The results demonstrate that people value activities beyond writing and analyzing data but the opinions are polarized. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0198117
An author submitted two manuscripts to our journal and the data were clearly fabricated, which was confirmed when we examined the original patient data files. The lead author admitted that they had only recruited a few patients and fabricated all of the remaining data and said that the co-authors had done this without their knowledge.
Changed title to match revision of All Flowcharts PDF
At the 2017 COPE European Seminar, Iain Hrynaszkiewicz, Head of Data Publishing at Springer Nature, talked about research data in the context of challenges and opportunities for publication ethics.
A reader contacted the journal to raise concerns about a paper containing a potentially manipulated figure. The editor-in-chief agreed with the assessment that the figure had been manipulated and attempted to contact the corresponding author, without response. Following further contact with the co-authors and institution, it was established that the corresponding author had retired after publication of the paper, and no current contact details could be found.
We received a letter from a third party, accusing author A of putting his/her name against an article, published in our journal, when the research itself belongs to author A's student.
A paper was submitted to our journal. The managing editor was concerned about patient information in the paper and queried the authors. The authors responded that the data were collected from routine samples and so consent was never obtained. The patients were lost to follow-up, and there was no ethics committee approval as it involved the study of existing data, but they did discuss with the institutional review board who said it was exempt.
The topic for discussion at the next Forum (12 February 2016, 3.00pm GMT - more details to follow shortly) is ‘Data sharing’. Data sharing is increasingly viewed as an essential step in improving research transparency and reproducibility. There has been a lot of discussion on the imperative for data sharing in the biomedical arena, particularly of publicly funded research. As a result, there are many disciplines where proposals for data sharing are being discussed.